Search for a clinical trial
Other search option(s)
9 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Funded by an IRDiRC member = 
National clinical trial(s)
UNITED KINGDOM
Oxfordshire
HEADINGTON
Phase II Clinical Trial of 6-Mercaptopurine(6MP)and low-dose Methotrexate In Patients With Known BRCA Defective Tumours. - A Phase II Clinical Trial in Patients with BRCA defective Tumours
Churchill Hospital
Level 0, Oxford Cancer Centre - medical oncology
UNITED KINGDOM
Oxfordshire
OXFORD
Phase II Clinical Trial of 6-Mercaptopurine(6MP)and low-dose Methotrexate In Patients With Known BRCA Defective Tumours. - A Phase II Clinical Trial in Patients with BRCA defective Tumours
University of Oxford
Oxford University Offices
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
An Open-Label, Multicohort, Phase II Study of Atezolizumab in Advanced Solid Tumors (Phase 2) - AT
Institution: Information not provided - AT
GERMANY
Berlin
ADDRESS: NOT PROVIDED - DE
Atezolizumab in Combination With Bevacizumab and Chemotherapy Versus Bevacizumab and Chemotherapy in Recurrent Ovarian Cancer - a Randomized Phase III Trial
Institution: Information not provided - DE
UNITED KINGDOM
Greater London
LONDON
A Phase II randomised, double blind, multicentre study to assess the efficacy of AZD2281 in the treatment of patients with platinum sensitive serous ovarian cancer following treatment with two or more platinum containing regimens - UK
UCLH Gynaecological Cancer Centre, University College London
UCLH Gynaecological Cancer Centre, Women's Health Office Wing, 2nd Floor, North Wing
UNITED KINGDOM
Greater London
LONDON
ICON 6: A phase III double-blind, placebo-controlled, three arm randomised multi-centre Gynaecologic Cancer InterGroup trial of AZD2171, in combination with platinum-based chemotherapy and as a single agent maintenance therapy, in women with ovarian cancer relapsing more than 6 months following completion of first line platinum-based treatment - UK
UCLH Gynaecological Cancer Centre, University College London
UCLH Gynaecological Cancer Centre, Women's Health Office Wing, 2nd Floor, North Wing
UNITED KINGDOM
Surrey
SUTTON
A Randomised, Phase II Study Evaluating MK-1775 in Combination with Paclitaxel and Carboplatin versus Paclitaxel and Carboplatin Alone in Adult Patients with Platinum Sensitive p53 Mutant Ovarian Cancer - UK
The Royal Marsden Hospital
Gynaecology Unit
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
STEP: Sorafenib Long Term Extension Program - BE
Cliniques Universitaires UCL Saint-Luc
Pneumologie_Oncologie thoracique
UNITED KINGDOM
Greater London
LONDON